METOANA

This brand name is authorized in Japan

Active ingredients

The drug METOANA contains a combination of these active pharmaceutical ingredients (APIs):

1 Anagliptin UNII K726J96838 - ANAGLIPTIN
Read about Anagliptin
2 Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. Read about Metformin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BH	Dipeptidyl peptidase 4 (DPP-4) inhibitors	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BH

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: JP	医薬品医療機器総合機構	Identifier(s): 3969109F1021, 3969109F2028

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.